CL King Downgrades Axonics to Neutral
Portfolio Pulse from Benzinga Newsdesk
CL King analyst Kristen Stewart has downgraded Axonics (NASDAQ:AXNX) from Buy to Neutral.

January 12, 2024 | 2:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Axonics has been downgraded by CL King analyst Kristen Stewart from Buy to Neutral, which may influence investor sentiment and stock performance.
Analyst downgrades typically lead to a negative perception among investors and can result in a short-term decline in the stock price. The downgrade from Buy to Neutral suggests a less optimistic outlook on the company's performance, which may lead to reduced investor confidence and selling pressure.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100